The global single-cell analysis market size is expected to reach USD 6.56 billion by 2028 according to a new study by Polaris Market Research. The report “Single-cell Analysis Market Share, Size, Trends, Industry Analysis Report, By Product (Consumables, Instruments); By Application; By Workflow; By End-Use; By Region; Segment Forecast, 2021-2028” gives a detailed insight into the current market dynamics and provides analysis on future market growth.
Increasing the adoption of the technology in diagnosing and monitoring diseases such as cancer and drug discovery techniques will be the significant factors contributing to global market growth. The increasing approvals for stem cell-based therapies and the emergence of COVID-19 are expected to boost the market’s growth further.
The technique is a great tool to detect cancer at an early stage. In the U.S. alone, cancer affected more than 2.2 million people, in 2020, with more than 0.6 million deaths. Treatments fail in cancer as they are diagnosed at an advanced stage. Still, the testing of circulating tumor cells can be detected at an early stage that will significantly help reduce mortality. The testing will also help in developing precision medicine based on the specific biomarker detection in cancer patients.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/single-cell-analysis-market/request-for-sample
Single-cell testing is employed in studying the pathogenesis and molecular mechanism of COVID-19. For instance, the technique was used to study the antiviral immunity defects in severely infected COVID-19 patients. The research study found that the patient who is severely affected by the disease have higher expression of apoptotic genes in their dendritic cells along with changes in the expression of primary histocompatibility class II-related genes in a dendritic cell subset known as cDC1c+ DCs that will affect the antigen presentation efficiency of these cells.
The testing has significant applications in the field of oncology, IVF, and Stem Cell technologies. Various technologies such as flow cytometry, polymerase chain reaction (PCR), microscopy, mass spectrometry, next-generation sequencing (NGS) is employed in single-cell testing. Flow cytometry-based testing is more popular than other methods as it can detect both the physical and genetic makeup of the cell.
New developments are taking place in the global market in recent times. For instance, CytoFLEX SRT Benchtop Sorter was launched by Beckman Coulter in March 2021. The expanded color and laser options will increase its use in testing in research laboratories. Similarly, in January 2021, Parse Biosciences received USD 7 million in Series A funding to develop single-cell kits.
Polaris Market Research has segmented the single-cell analysis market report on the basis of product, application, workflow, end-use and region:
Single-cell Analysis, Product Outlook (Revenue – USD Million, 2016 – 2028)
- Assay kits
- Flow cytometers
- Next-Generation Sequencing (NGS) systems
- Polymerase Chain Reaction (PCR) instruments
- High content screening systems
- Cell microarrays
- Automated cell counters
- Single live cell imaging
Single-cell Analysis, Application Outlook (Revenue – USD Million, 2016 – 2028)
- Stem Cell
- Non-invasive Prenatal Diagnosis
- In-vitro Fertilization
Single-cell Analysis, Workflow Outlook (Revenue – USD Million, 2016 – 2028)
- Single-cell isolation & Library Preparation
Single-cell Analysis, End-Use Outlook (Revenue – USD Million, 2016 – 2028)
- Academic & Research Laboratories
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
Single-cell Analysis, Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa